Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study

Código QR

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study

Background and study aims Nonalcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease worldwide with limited treatment options. Duodenal mucosal resurfacing (DMR) has been associated with improvement in glycaemic parameters and liver function tests (LFTs) in type 2 diabetes. This...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alia Hadefi, Laurine Verset, Martina Pezzullo, Nicolas Rosewick, Delphine Degré, Thierry Gustot, Christophe Moreno, Jacques Devière, Eric Trépo
Formato:	article
Lenguaje:	EN
Publicado:	Georg Thieme Verlag KG 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/f44acbdadf45498caa5435da28ad57f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
por: Xuerong Wen, et al.
Publicado: (2021)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu HH, et al.
Publicado: (2019)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Tae Hyung Kim, et al.
Publicado: (2021)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
por: D. H. Ipsen, et al.
Publicado: (2021)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
por: Kawanaka M, et al.
Publicado: (2013)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
por: Guangyong Sun, et al.
Publicado: (2021)

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
por: Mimi Zhai, et al.
Publicado: (2021)

Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
por: Kook Hwan Kim, et al.
Publicado: (2018)

Rat model of nonalcoholic steatohepatitis created by methionine and choline deficiency: biochemical and histological analyses
por: Seki A, et al.
Publicado: (2011)

Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
por: Chengyuan Liang, et al.
Publicado: (2021)

β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
por: Masuko Kobori, et al.
Publicado: (2014)

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
por: Hegazy MA, et al.
Publicado: (2019)

The sex steroid precursor dehydroepiandrosterone prevents nonalcoholic steatohepatitis by activating the AMPK pathway mediated by GPR30
por: Longlong Li, et al.
Publicado: (2021)

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT PathwaySummary
por: Feixue Wang, et al.
Publicado: (2022)

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
por: Diaz Soto MP, et al.
Publicado: (2020)

Recent advances in prevention and management of endoscopic retrograde cholangiopancreatography-related duodenal perforation
por: Guiying Zhu, et al.
Publicado: (2020)

The mechanism of increased intestinal palmitic acid absorption and its impact on hepatic stellate cell activation in nonalcoholic steatohepatitis
por: Masakazu Hanayama, et al.
Publicado: (2021)

Unacceptable failure of osteochondral glenoid allograft for biologic resurfacing of the glenoid
por: Filippo Familiari, et al.
Publicado: (2021)

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial
por: Alam S, et al.
Publicado: (2018)

Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
por: Sandip Mukherjee, et al.
Publicado: (2021)

John Forbes Nash /
por: Flores, Néstor, et al.
Publicado: (2005)

Endoscopic negative pressure therapy as stand-alone treatment for perforated duodenal diverticulum: presentation of two cases
por: Dörte Wichmann, et al.
Publicado: (2021)

Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
por: VARELA,NELSON M, et al.
Publicado: (2008)

A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models
por: Nadine Daou, et al.
Publicado: (2021)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
por: Seko Y, et al.
Publicado: (2018)

AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
por: Hongjiao Xu, et al.
Publicado: (2020)

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
por: Divya P. Kumar, et al.
Publicado: (2020)

Computational modelling of hip resurfacing arthroplasty investigating the effect of femoral version on hip biomechanics.
por: Jonathan Bourget-Murray, et al.
Publicado: (2021)

SPECTRUM OF HISTOPATHOLOGICAL PATTERNS OF DUODENAL BIOPSIES IN PATIENTS WITH UNEXPLAINED ANAEMIA AND CHRONIC DIARRHEA AND THEIR CORRELATION WITH ENDOSCOPIC FINDINGS AND SEROLOGICAL MARKERS
por: Muhammad Awais Yasin, et al.
Publicado: (2021)

Quantum gambling based on Nash-equilibrium
por: Pei Zhang, et al.
Publicado: (2017)

Endoscopic resection outcomes and predictors of failed en bloc endoscopic mucosal resection of colorectal polyps ≤ 20 mm among advanced endoscopy trainees
por: William W. King, et al.
Publicado: (2021)

Resurfacing the donor sites of reverse sural artery flaps using thoracodorsal artery perforator flaps
por: Se Won Oh, et al.
Publicado: (2021)

Author Correction: AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
por: Hongjiao Xu, et al.
Publicado: (2021)

Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study.
por: Eun-Hee Nah, et al.
Publicado: (2021)

Current and Potential Therapies Targeting Inflammation in NASH
por: Somaya Albhaisi, et al.
Publicado: (2021)

Nash equilibria in multi-agent motor interactions.
por: Daniel A Braun, et al.
Publicado: (2009)

Anchoring the snare tip is a feasible endoscopic mucosal resection method for small rectal neuroendocrine tumors
por: Jeongseok Kim, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)

Equilibrio de Nash para el segundo nivel
por: López Utrera, Luis Rodrigo
Publicado: (2015)